Advertisement
Original article| Volume 40, ISSUE 6, P452-456, September 15, 1996

Electroencephalography in schizophrenic patients: Comparison between neuroleptic-naive state and after treatment

  • Yasuko Nagase
    Correspondence
    Address reprint requests to Dr. Yasuko Nagase, Department of Neuropsychiatry, Tokyo Medical and Dental University, School of Medicine, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113, Japan.
    Affiliations
    Department of Neuropsychiatry, Tokyo Medical and Dental University, School of Medicine, Tokyo, Japan
    Search for articles by this author
  • Yoshiro Okubo
    Affiliations
    Department of Neuropsychiatry, Tokyo Medical and Dental University, School of Medicine, Tokyo, Japan
    Search for articles by this author
  • Michio Toru
    Affiliations
    Department of Neuropsychiatry, Tokyo Medical and Dental University, School of Medicine, Tokyo, Japan
    Search for articles by this author
DOI:https://doi.org/10.1016/0006-3223(96)00304-6
Electroencephalography in schizophrenic patients: Comparison between neuroleptic-naive state and after treatment
Previous ArticleRelationships between verbal memory performance and the cerebral distribution of fluorodeoxyglucose in patients with schizophrenia
Next ArticleX chromosome and infantile autism
      This paper is only available as a PDF. To read, Please Download here.
      Electroencephalography of 12 schizophrenic patients was recorded in a neuroleptic-naive state and after 6.2 ± 1.1 months of treatment, when they were on medication and in partial remission. Compared with age- and sex-matched controls, the neuroleptic-naive schizophrenics had less alpha 2 power. In the medicated state, alpha 2 power and slow-wave power were reduced as compared with the neuroleptic-naive state. The reduction in alpha 2 power may occur from the early stage of the disease and progress even though the patients are medicated and clinically improved.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Czobor P
        • Volavka J
        Level of haloperidol in plasma is related to electroencephalographic findings in patients who improve.
        Psychiatry Res. 1992; 42: 129-144
        • Czobor P
        • Volavka J
        Quantitative electroencephalogram examination of effects of risperidone in schizophrenic patients.
        J Clin Psychopharmacol. 1993; 13: 332-342
        • Duffy FH
        • Barteles PH
        • Burchtiel JL
        Significance probability mapping: An aid in the topographic analysis of brain electrical activity.
        Electroencephalogr Clin Neurophysiol. 1981; 51: 455-462
        • Fink M
        Quantitative EEG in human psychopharmacology: Drug patterns.
        in: von Glaser EEG and Behavior. Basic Books, Stuttgart1963: 177-197
        • Gattaz WF
        • Mayer S
        • Ziegler P
        • et al.
        Hypofrontality on topographic EEG in schizophrenia.
        Eur Arch Psychiatry Clin Neurosci. 1992; 241: 328-332
        • Gunther W
        • Davous P
        • Godet JL
        • et al.
        Bilateral brain dysfunction during motor activation in type II schizophrenia measured by EEG mapping.
        Biol Psychiatry. 1988; 23: 295-311
        • Itil TM
        Qualitative and quantitative EEG findings in schizophrenia.
        Schizoph Bull. 1977; 3: 61-79
        • Kemali D
        • Vacca L
        • Marciano FL
        • et al.
        Computerized EEG in schizophrenics.
        Neuropsychobiology. 1980; 6: 260-267
        • Kemali D
        • Galderisi S
        • Maj M
        • et al.
        Computerized EEG topography findings in schizophrenic patients before and after haloperidol treatment.
        Int J Psychophysiol. 1992; 13: 283-290
        • Koukkou M
        EEG and behavioral differences between first acute schizophrenic episode and remission.
        in: Perris C Kemali D Vacca L Advances in Biological Psychiatry. Vol. 6. Karger, New York1981: 35
        • Morihisa JM
        • Duffy FH
        • McCarley RW
        BEAM in schizophrenic patients.
        Arch Gen Psychiatry. 1983; 40: 719-728
        • Morstyn R
        • Duffy FH
        • McCarley RW
        Altered topography of EEG spectral content in schizophrenia.
        Electroencephalogr Clin Neurophysiol. 1983; 56: 263-271
        • Nagase Y
        • Okubo Y
        • Matsuura M
        • et al.
        Topographical changes in alpha power in medicated and unmedicated schizophrenics during digits span reverse matching test.
        Biol Psychiatry. 1992; 32: 870-879
        • Nagase Y
        • Okubo Y
        • Matsuura M
        • et al.
        EEG coherence in unmedicated schizophrenic patients.
        Biol Psychiatry. 1992; 32: 1028-1034
        • Roberts GW
        • Bruton CJ
        Notes from the graveyard: Neuropathology and schizophrenia.
        Neuropathol Appl Neurobiol. 1990; 16: 3-16
        • Saletu B
        • Grunberger J
        • Linzmayer L
        Classification and determination of cerebral bioavailability of psychotropic drugs by quantitative “pharmaco-EEG” and psychometric investigations.
        Int J Clin Pharmacol Biopharm. 1977; 15 (studies with AX-A411-BS): 449-459
        • Saletu B
        • Kufferie B
        • Anderer P
        • et al.
        EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms.
        Eur-Neuropsychopharmacol. 1990; 1: 27-36
        • Shagass C
        • Roemer RA
        • Straumanis JJ
        • et al.
        Psychiatric diagnostic discriminations with combinations of quantitative EEG variables.
        Br J Psychiatry. 1984; 144: 581-592
        • Small JG
        • Milstein V
        • Small IF
        • et al.
        Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia.
        Clin-Electroencephalogr. 1987; 18: 124-135
        • Toru M
        Pharmacology of Schizophrenics.
        Chugai Medical Press, Basel1983

      Article info

      Publication history

      Received in revised form: May 4, 1995
      Received: July 8, 1994

      Identification

      DOI: https://doi.org/10.1016/0006-3223(96)00304-6

      Copyright

      © 1996 Society of Biological Psychiatry. Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX